CASSANDRE
Phase 2 Terminated
11 enrolled
PROACT
Phase 2 Terminated
49 enrolled 12 charts
STARBURST
Phase 2 Terminated
11 enrolled
Study of Seribantumab in Adult Patients With NRG1 Gene Fusion Positive Advanced Solid Tumors
Phase 2 Terminated
54 enrolled 11 charts
TTI-621-03
Phase 2 Terminated
76 enrolled 53 charts
Pazopanib Maintenance Phase II
Phase 2 Terminated
1 enrolled 4 charts
Palbociclib + Ganitumab In Ewing Sarcoma
Phase 2 Terminated
10 enrolled 15 charts
UVA-Gen001
Phase 2 Terminated
4 enrolled 16 charts
A Study of SHR-1210 Plus Apatinib in Patients With Soft Tissue Sarcoma
Phase 2 Terminated
99 enrolled 10 charts
LODESTAR
Phase 2 Terminated
83 enrolled 16 charts
A Study of PRO95780 in Patients With Advanced Chondrosarcoma (APM4171g)
Phase 2 Terminated
15 enrolled
A Study of Anti-CTLA-4 Antibody in Patients With Advanced Synovial Sarcoma
Phase 2 Terminated
6 enrolled 8 charts
ANITA
Phase 2 Terminated
80 enrolled
A Study of R1507 in Participants With Recurrent or Refractory Sarcoma
Phase 2 Terminated
317 enrolled 27 charts
NOPASS
Phase 2 Terminated
21 enrolled
Gemcitabine Plus Ascorbate for Sarcoma in Adults
Phase 2 Terminated
10 enrolled 13 charts
Sorafenib and Ifosfamide in Treating Patients With High-Grade Soft Tissue Sarcoma or Bone Sarcoma That Can Be Removed by Surgery
Phase 2 Terminated
7 enrolled 5 charts
IMDZ-C232
Phase 2 Terminated
89 enrolled 24 charts
HYPAZ
Phase 2 Terminated
31 enrolled
Efficacy and Safety Study of CC-4047 (Pomalidomide) to Treat Advanced Soft Tissue Sarcoma
Phase 2 Terminated
7 enrolled 7 charts
Sunitinib in Certain Subtypes of Soft Tissue Sarcomas
Phase 2 Terminated
10 enrolled 6 charts
Combination of External Beam Radiotherapy With 153Sm-EDTMP to Treat High Risk Osteosarcoma
Phase 2 Terminated
4 enrolled 9 charts
A Japanese Trial of TH-302 in Subjects With Locally Advanced Unresectable or Metastatic Soft Tissue Sarcoma
Phase 2 Terminated
6 enrolled 6 charts
Cryoablation, Radiofrequency Ablation, or Microwave Ablation in Treating Patients With Metastatic Sarcoma Stable on Chemotherapy
Phase 2 Terminated
9 enrolled 13 charts
Paclitaxel in Treating Patients With Recurrent or Persistent Cancer of the Uterus
Phase 2 Terminated
18F-Fluoromisonidazole and Fludeoxyglucose F 18 PET/CT Patients With Soft Tissue Sarcoma
Phase 2 Terminated
8 enrolled 4 charts
Antineoplaston Therapy in Treating Patients With Soft Tissue Sarcoma
Phase 2 Terminated
14 enrolled
Conformal Radiation Therapy in Treating Patients With Metastatic Cancer Outside the Brain
Phase 2 Terminated
1 enrolled 7 charts
Study of 18F-Fluorodeoxyglucose (FluGlucoScan) in Patients With Known or Suspected Soft Tissue Sarcoma
Phase 2 Terminated
4 enrolled
A Phase II Trial of Combined Hydroxychloroquine and Sirolimus in Soft Tissue Sarcoma
Phase 2 Terminated
13 enrolled 4 charts
Doxorubicin vs. Trabectedin Plus Doxorubicin in Non Operable and/or Metastatic STS
Phase 2 Terminated
115 enrolled
Combination Chemotherapy Before and After Surgery in Treating Patients With Osteosarcoma
Phase 2 Terminated
100 enrolled
Phase II Study of Doxorubicin and Avastin® in Sarcoma.
Phase 2 Terminated
4 enrolled 4 charts
BMS-247550 in Treating Patients With Advanced Soft Tissue Sarcoma
Phase 2 Terminated
26 enrolled
Surgery and/or Chemotherapy in Treating Children With Infantile, Congenital, or Childhood Fibrosarcoma
Phase 2 Terminated
7 enrolled 9 charts
Combination Chemotherapy and Dexrazoxane Followed by Surgery and Radiation Therapy in Treating Patients With Advanced Soft Tissue Sarcoma or Recurrent Bone Sarcoma
Phase 2 Terminated
7 enrolled 2 charts
Intensity-Modulated Radiation Therapy in Treating Patients Undergoing Surgery for Stage IB, Stage II, or Stage III Soft Tissue Sarcoma
Phase 2 Terminated
1 enrolled 3 charts
Study of RAD001 in Soft Tissue Extremity and/or Retroperitoneal Sarcomas
Phase 2 Terminated
2 enrolled 3 charts
Combination Chemotherapy in Treating Patients With Recurrent or Advanced Cancer of the Uterus
Phase 2 Terminated
30 enrolled
Topotecan in Treating Patients With Recurrent or Refractory Cancer of the Uterus
Phase 2 Terminated
Gemcitabine in Treating Patients With Recurrent or Refractory Cancer of the Uterus
Phase 2 Terminated
Amifostine in Treating Women With Ovarian, Peritoneal, Cervical, Fallopian Tube, Uterine, or Endometrial Cancer
Phase 2 Terminated
Combination Chemotherapy Plus Sargramostim in Treating Patients With Cancer of the Uterus
Phase 2 Terminated
Chemotherapy in Treating Patients With Metastatic Ewing's Sarcoma or Primitive Neuroectodermal Tumor
Phase 2 Terminated
3 enrolled